While recreational and medical marijuana are slowly infiltrating the market, CBD is as well. Unlike marijuana, however, the CBD business avoids all of the legality issues of selling and distributing the highly-debated drug.
CBD stands for cannabidoil and does not contain THC, so CBD won’t get a person high. It is used for pain management and to treat anxiety and depression, immune issues and more. CBD is a $1 billion industry, and its sales are estimated to grow to a whopping $22 billion by 2022. The most common CBD product is CBD oil, which can be taken as a dietary supplement, as drops, through an e-cigarette and even as lotion.
Sativa Investments (LON:SATI) seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest